Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
Please note that COPYRIGHT in the paper is owned by the British Association for Psychopharmacology (BAP). SINGLE ISSUE USE ONLY (and printing) for PERSONAL RESEARCH ONLY is acceptable. Information on where to apply for reprints and supplements is included below.
Contact: Blanca Bolea
Address: University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, UK